Filing Details
- Accession Number:
- 0001127602-18-015508
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-30 15:15:42
- Reporting Period:
- 2018-04-27
- Accepted Time:
- 2018-04-30 15:15:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238330 | Ann Jo Golden | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-04-27 | 2,698 | $41.06 | 19,480 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-04-27 | 5,698 | $65.40 | 13,782 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options To Purchase Common Stock | Disposition | 2018-04-27 | 2,698 | $0.00 | 2,698 | $41.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,698 | 2017-06-01 | 2026-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.19 to $65.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.